Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (45230)
All Articles published online
|
Publishing Process of This Article
|
Jul 27, 2013 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Teschke R, Frenzel C, Schulze J, Schwarzenboeck A, Eickhoff A. Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests. World J Hepatol 2013; 5(7): 353-363 [PMID: 23898368 DOI: 10.4254/wjh.v5.i7.353] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i7/353.htm |
| Number | Citing Articles |
| 1 |
Gaby Danan, Rolf Teschke. RUCAM in Drug and Herb Induced Liver Injury: The Update. International Journal of Molecular Sciences 2015; 17(1): 14 doi: 10.3390/ijms17010014
|
| 2 |
Bernard Kamsu-Foguem, Clovis Foguem. Adverse drug reactions in some African herbal medicine: literature review and stakeholders’ interview. Integrative Medicine Research 2014; 3(3): 126 doi: 10.1016/j.imr.2014.05.001
|
| 3 |
Rolf Teschke. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method. Expert Opinion on Drug Metabolism & Toxicology 2018; : 1 doi: 10.1080/17425255.2018.1539077
|
| 4 |
Rolf Teschke, Dominique Larrey, Dieter Melchart, Gaby Danan. Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs. Medicines 2016; 3(3): 18 doi: 10.3390/medicines3030018
|
| 5 |
Anna Licata, Antonio Craxì. Considerations regarding the alleged association between Herbalife products and cases of hepatotoxicity: a rebuttal. Internal and Emergency Medicine 2014; 9(5): 601 doi: 10.1007/s11739-014-1062-y
|
| 6 |
Rolf Teschke, Alexander Schwarzenboeck, Christian Frenzel, Johannes Schulze, Axel Eickhoff, Albrecht Wolff. The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem. Annals of Hepatology 2016; 15(1): 91 doi: 10.5604/16652681.1184237
|
| 7 |
Flávio Ailton Duque Zambrone, Cristiana Leslie Corrêa, Ligia Mesquita Sampaio do Amaral. A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife (r) products. Brazilian Journal of Pharmaceutical Sciences 2015; 51(4): 785 doi: 10.1590/S1984-82502015000400004
|
| 8 |
Rolf Teschke, Christian Frenzel. Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?. Annals of Hepatology 2014; 13(1): 121 doi: 10.1016/S1665-2681(19)30913-5
|
| 9 |
Shafagh Fallah, Kathy Musa-Veloso, Joyce Cao, Carolina Venditti, Han Youl Lee, Samer Hamamji, Jiang Hu, Kristy Appelhans, Vasilios Frankos. Liver biomarkers in adults: Evaluation of associations with reported green tea consumption and use of green tea supplements in U.S. NHANES. Regulatory Toxicology and Pharmacology 2022; 129: 105087 doi: 10.1016/j.yrtph.2021.105087
|
| 10 |
Christian Frenzel, Rolf Teschke. Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. International Journal of Molecular Sciences 2016; 17(5): 588 doi: 10.3390/ijms17050588
|
| 11 |
Kristy Appelhans, Raushanah Najeeullah, Vasilios Frankos. Deficiencies Identified in Dated Case Reports Associated With Herbalife. Journal of Pharmacy Practice 2015; 28(5): 484 doi: 10.1177/0897190015598238
|
| 12 |
Rolf Teschke, Albrecht Wolff, Axel Eickhoff, Gaby Danan. Is obesity rather than the dietary supplement used for weight reduction the cause of liver injury?. JGH Open 2018; 2(4): 152 doi: 10.1002/jgh3.12057
|
| 13 |
Gaby Danan, Rolf Teschke. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?. Drug Safety 2018; 41(8): 735 doi: 10.1007/s40264-018-0654-2
|
| 14 |
Cyriac A. Philips, Philip Augustine, Sasidharan Rajesh, Solomon K. John, Gopakumar C. Valiathan, Jos Mathew, Sameer Phalke, Kuruveetil L. Antony. REMOVED: Slimming to the Death: Herbalife®-Associated Fatal Acute Liver Failure—Heavy Metals, Toxic Compounds, Bacterial Contaminants and Psychotropic Agents in Products Sold in India. Journal of Clinical and Experimental Hepatology 2019; 9(2): 268 doi: 10.1016/j.jceh.2018.08.002
|
| 15 |
Rolf Teschke, Axel Eickhoff, Amy C. Brown, Manuela G. Neuman, Johannes Schulze. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. International Journal of Molecular Sciences 2019; 21(1): 212 doi: 10.3390/ijms21010212
|
| 16 |
Rolf Teschke, Gaby Danan. Pharmacovigilance for Herbal and Traditional Medicines. 2022; : 189 doi: 10.1007/978-3-031-07275-8_10
|
| 17 |
Vasilios Frankos, Raushanah Najeeullah, Joel Morgan. Critical Evaluation for Alternative Causes of Drug Induced and Herbal Induced (DILI/HILI) Hepatotoxicity. Health 2016; 8(09): 800 doi: 10.4236/health.2016.89084
|
| 18 |
Rolf Teschke, Gaby Danan. Drug-Induced Liver Toxicity. Methods in Pharmacology and Toxicology 2018; : 555 doi: 10.1007/978-1-4939-7677-5_27
|
| 19 |
Walid M Chalhoub, Kayla D Sliman, Meera Arumuganathan, James H Lewis. Drug-induced liver injury: what was new in 2013?. Expert Opinion on Drug Metabolism & Toxicology 2014; 10(7): 959 doi: 10.1517/17425255.2014.909408
|
| 20 |
Brandon J. Perumpail, Rosann Cholankeril, Eric R. Yoo, Donghee Kim, Aijaz Ahmed. An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. Diseases 2017; 5(4): 23 doi: 10.3390/diseases5040023
|
| 21 |
Arie Regev, Leonard B. Seeff, Michael Merz, Sif Ormarsdottir, Guruprasad P. Aithal, Jim Gallivan, Paul B. Watkins. Causality Assessment for Suspected DILI During Clinical Phases of Drug Development. Drug Safety 2014; 37(S1): 47 doi: 10.1007/s40264-014-0185-4
|
| 22 |
Yun Zhu, Ming Niu, Jing Chen, Zheng‐sheng Zou, Zhi‐jie Ma, Shu‐hong Liu, Rui‐lin Wang, Ting‐ting He, Hai‐bo Song, Zhong‐xia Wang, Shi‐biao Pu, Xiao Ma, Li‐fu Wang, Zhao‐fang Bai, Yan‐ling Zhao, Yong‐gang Li, Jia‐bo Wang, Xiao‐he Xiao. Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine‐induced liver injury of 1985 patients. Journal of Gastroenterology and Hepatology 2016; 31(8): 1476 doi: 10.1111/jgh.13323
|
| 23 |
Kristy Appelhans, Raushanah Najeeullah, Vasilios Frankos. Considerations regarding the alleged association between Herbalife products and cases of hepatotoxicity. Internal and Emergency Medicine 2014; 9(5): 599 doi: 10.1007/s11739-014-1048-9
|
| 24 |
Rolf Teschke, Alexander Genthner, Albrecht Wolff, Christian Frenzel, Johannes Schulze, Axel Eickhoff. Herbal hepatotoxicity: Analysis of cases with initially reported positive re-exposure tests. Digestive and Liver Disease 2014; 46(3): 264 doi: 10.1016/j.dld.2013.10.020
|
| 25 |
Rolf Teschke, Li Zhang, Hongzhu Long, Alexander Schwarzenboeck, Wolfgang Schmidt-Taenzer, Alexander Genthner, Albrecht Wolff, Christian Frenzel, Johannes Schulze, Axel Eickhoff. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Annals of Hepatology 2015; 14(1): 7 doi: 10.1016/S1665-2681(19)30796-3
|
| 26 |
Amy Christine Brown. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food and Chemical Toxicology 2017; 107: 472 doi: 10.1016/j.fct.2016.07.001
|